Litcius/Paper detail

Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial

Raj Makkar, Wen Cheng, Ron Waksman, Lowell F. Satler, Tarun Chakravarty, Mark A. Groh, William B. Abernethy, Mark J. Russo, David Heimansohn, James Hermiller, Stephen G. Worthley, Bassem Chehab, Mark J. Cunningham, Ray Matthews, Ravi K Ramana, Gerald Yong, Carlos E. Ruiz, Chunguang Chen, Federico M. Asch, Mamoo Nakamura, Hasan Jilaihawi, Rahul Sharma, Sung-Han Yoon, Augusto D. Pichard, Samir Kapadia, Michael J. Reardon, Deepak L. Bhatt, Gregory P. Fontana

2020The Lancet134 citationsDOI

Topics & Concepts

MedicineInvestigational device exemptionStenosisAortic valve stenosisSurgeryClinical endpointStroke (engine)Randomized controlled trialAortic valveAortic valve replacementClinical trialValve replacementDialysisInternal medicineCardiologyMechanical engineeringEngineeringCardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesCardiac and Coronary Surgery Techniques
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial | Litcius